Is post-discharge bleeding associated with increased subsequent all-cause mortality in patients with acute coronary syndrome treated with or without PCI?
45,011 patients with acute coronary syndrome (ACS) from a harmonized dataset of 4 multicenter randomized trials (APPRAISE-2, PLATO, TRACER, and TRILOGY ACS)
Post-discharge non-CABG-related GUSTO moderate, severe, or life-threatening bleeding (landmark 7 days post-ACS)
No post-discharge bleeding
Subsequent all-cause mortalityhard clinical
Post-discharge bleeding after ACS carries a similar prognostic impact on mortality as post-discharge MI, regardless of whether the patient was initially treated with PCI.
BACKGROUND The long-term prognostic impact of post-discharge bleeding in the unique population of patients with acute coronary syndrome (ACS) treated without percutaneous coronary intervention (PCI) remains unexplored. OBJECTIVES The aim of this study was to assess the association between post-discharge bleeding and subsequent mortality after ACS according to index strategy (PCI or no PCI) and to contrast with the association between post-discharge myocardial infarction (MI) and subsequent mortality. METHODS In a harmonized dataset of 4 multicenter randomized trials (APPRAISE-2 Apixaban for Prevention of Acute Ischemic Events-2, PLATO Study of Platelet Inhibition and Patient Outcomes, TRACER Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome, and TRILOGY ACS Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes), the association between post-discharge noncoronary artery bypass graft-related GUSTO (Global Use of Strategies to Open Occluded Coronary Arteries) moderate, severe, or life-threatening bleeding (landmark 7 days post-ACS) and subsequent all-cause mortality was evaluated in a time-updated Cox proportional hazards analysis. Interaction with index treatment strategy was assessed. Results were contrasted with risk for mortality following post-discharge MI. RESULTS Among 45,011 participants, 1,133 experienced post-discharge bleeding events (2.6 per 100 patient-years), and 2,149 died during follow-up. The risk for mortality was significantly higher <30 days (adjusted hazard ratio: 15.7; 95% confidence interval: 12.3 to 20.0) and 30 days to 12 months (adjusted hazard ratio: 2.7; 95% confidence interval: 2.1 to 3.4) after bleeding, and this association was consistent in participants treated with or without PCI for their index ACS (p for interaction = 0.240). The time-related association between post-discharge bleeding and mortality was similar to the association between MI and subsequent mortality in participants treated with and without PCI (p for interaction = 0.696). CONCLUSIONS Post-discharge bleeding after ACS is associated with a similar increase in subsequent all-cause mortality in participants treated with or without PCI and has an equivalent prognostic impact as post-discharge MI.
Building similarity graph...
Analyzing shared references across papers
Loading...
Guillaume Marquis‐Gravel
Interventional Cardiology
Frederik Dalgaard
Gentofte Hospital
Aaron D. Jones
University of Maryland, Baltimore
Journal of the American College of Cardiology
Stanford University
Inserm
Duke University
Building similarity graph...
Analyzing shared references across papers
Loading...
Marquis‐Gravel et al. (Wed,) studied this question.
synapsesocial.com/papers/6a29d4c9c0472106186ba12c — DOI: https://doi.org/10.1016/j.jacc.2020.05.031
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: